Erratum: Identification of two novel Chlorotoxin derivatives CA4 and CTX-23 with chemotherapeutic and anti-angiogenic potential (Scientific Reports (2016) 6 (19799) DOI: 10.1038/srep19799);Identification of two novel Chlorotoxin derivatives CA4 and CTX-23 with chemotherapeutic and anti-angiogenic potential

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Xu, Tengfei ^a   Fan, Zheng ^a   Li, Wenxin ^b   Dietel, Barbara ^c   Wu, Yingliang ^b   Beckmann, Matthias W ^c   Wrosch, Jana K ^c   Buchfelder, Michael ^a   Eyupoglu, Ilker Y ^a   Cao, Zhijian ^b   Savaskan, Nicolai E ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b WUHAN UNIVERSITY   (China)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; CHLOROTOXIN; SCORPION VENOM;

ANIMAL; BRAIN NEOPLASMS; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; GLIOMA; HUMAN; METABOLISM; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; RAT; TUMOR CELL LINE; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; GLIOMA; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; RATS; SCORPION VENOMS;

EID: 84956598433     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep22206     Document Type: Erratum

References (43)

1. DeBin, J. A., Strichartz, G. R. Chloride channel inhibition by the venom of the scorpion Leiurus quinquestriatus. Toxicon. 29(11), 1403-8 (1991).
2. DeBin, J. A., Maggio, J. E., Strichartz, G. R. Purification and characterization of chlorotoxin, a chloride channel ligand from the venom of the scorpion. Am J Physiol 264 (2 Pt 1), C361-9 (1993).
3. Cheng, Y., Zhao, J., Qiao, W. et al. Recent advances in diagnosis and treatment of gliomas using chlorotoxin-based bioconjugates. Am J Nucl Med Mol Imaging 4(5), 385-405 (2014).
4. MFME, F. C. Scorpion neurotoxins: effects and mechanisms. In Chang L. W., Dyer R. S. (Eds), Handbook on Neurotoxicology, Marcel Dekker, New York; 683-716 (1995).
5. Seyedian, R., Pipelzadeh, M. H., Jalali, A. et al. Enzymatic analysis of Hemiscorpius lepturus scorpion venom using zymography and venom-specific antivenin. Toxicon 56(4), 521-5 (2010).
6. Quintero-Hernandez, V., Ortiz, E., Rendon-Anaya, M. et al. Scorpion and spider venom peptides: gene cloning and peptide expression. Toxicon 58(8), 644-63 (2011).
7. Possani, L. D., Becerril, B., Delepierre, M. et al. Scorpion toxins specific for Na+-channels. Eur J Biochem 264(2), 287-300 (1999).
8. Valdivia, H. H., Possani, L. D. Peptide toxins as probes of ryanodine receptor structure and function. Trends Cardiovasc Med 8(3), 111-8 (1998).
9. Tytgat, J., Chandy, K. G., Garcia, M. L. et al. A unified nomenclature for short-chain peptides isolated from scorpion venoms: alpha-KTx molecular subfamilies. Trends Pharmacol Sci 20(11), 444-7 (1999).
10. Batista, C. V., Gomez-Lagunas, F., Rodriguez de la Vega, R. C. et al. Two novel toxins from the Amazonian scorpion Tityus cambridgei that block Kv1.3 and Shaker B K(+ )-channels with distinctly different affinities. Biochim Biophys Acta 1601(2), 123-31 (2002).
11. Ullrich, N., Gillespie, G. Y., Sontheimer, H. Human astrocytoma cells express a unique chloride current. Neuroreport 7(5), 1020-4 (1996).
12. Ullrich, N., Sontheimer, H. Biophysical and pharmacological characterization of chloride currents in human astrocytoma cells. Am J Physiol 270 (5 Pt 1), C1511-21 (1996).
13. Ullrich, N., Sontheimer, H. Cell cycle-dependent expression of a glioma-specific chloride current: proposed link to cytoskeletal changes. Am J Physiol 273 (4 Pt 1), C1290-7 (1997).
14. Haas, B. R., Sontheimer, H. Inhibition of the Sodium-Potassium-Chloride Cotransporter Isoform-1 reduces glioma invasion. Cancer Res 70(13), 5597-606 (2010).
15. Habela, C. W., Olsen, M. L., Sontheimer, H. ClC3 is a critical regulator of the cell cycle in normal and malignant glial cells. J Neurosci 28(37), 9205-17 (2008).
16. Habela, C. W., Ernest, N. J., Swindall, A. F. et al. Chloride accumulation drives volume dynamics underlying cell proliferation and migration. J Neurophysiol 101(2), 750-7 (2009).
17. Watkins, S., Robel, S., Kimbrough, I. F. et al. Disruption of astrocyte-vascular coupling and the blood-brain barrier by invading glioma cells. Nat Commun 5, 4196 (2014).
18. Zeng, X. C., Li, W. X., Zhu, S. Y. et al. Cloning and characterization of a cDNA sequence encoding the precursor of a chlorotoxin-like peptide from the Chinese scorpion Buthus martensii Karsch. Toxicon 38(8), 1009-14 (2000).
19. Fan, S., Sun, Z., Jiang, D. et al. BmKCT toxin inhibits glioma proliferation and tumor metastasis. Cancer Lett 291(2), 158-66 (2010).
20. Sehm, T., Fan, Z., Weiss, R. et al. The impact of dietary isoflavonoids on malignant brain tumors. Cancer Med 3(4), 865-77 (2014).
21. Eyupoglu, I. Y., Savaskan, N. E., Brauer, A. U. et al. Identification of neuronal cell death in a model of degeneration in the hippocampus. Brain Res Brain Res Protoc 11(1), 1-8 (2003).
22. Hock, S. W., Fan, Z., Buchfelder, M. et al. Brain Tumor-Induced Angiogenesis: Approaches and Bioassays. Evolution of the Molecular Biology of Brain Tumors and the Therapeutic Implications 638, 125-145 (2013).
23. Sander, E. E., ten Klooster, J. P., van Delft, S. et al. Rac downregulates Rho activity: reciprocal balance between both GTPases determines cellular morphology and migratory behavior. J Cell Biol 147(5), 1009-22 (1999).
24. Yu, X. F., Sun, Z., Li, M. et al. Neurotoxin-conjugated upconversion nanoprobes for direct visualization of tumors under nearinfrared irradiation. Biomaterials 31(33), 8724-31 (2010).
25. Eyupoglu, I. Y., Hahnen, E., Heckel, A. et al. Malignant glioma-induced neuronal cell death in an organotypic glioma invasion model. Technical note. J Neurosurg 102(4), 738-44 (2005).
26. Storring, F. K., Duguid, J. B. The vascular formations in glioblastoma. J Pathol Bacteriol 68(1), 231-3 (1954).
27. Kroh, H., Stoltenburg-Didinger, G. Vascular response in experimental spinal cord gliomas of the rat. Zentralbl Allg Pathol 134(6), 523-30 (1988).
28. Yuan, F., Salehi, H. A., Boucher, Y. et al. Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res 54(17), 4564-8 (1994).
29. Eyupoglu, I. Y., Hore, N., Fan, Z. et al. Intraoperative vascular DIVA surgery reveals angiogenic hotspots in tumor zones of malignant gliomas. Sci Rep 5, 7958 (2015).
30. Eyupoglu, I. Y., Buchfelder, M., Savaskan, N. E. Surgical resection of malignant gliomas-role in optimizing patient outcome. Nat Rev Neurol 9(3), 141-51 (2013).
31. Jain, R. K. Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers. J Clin Oncol 31(17), 2205-18 (2013).
32. Hoffmann, E. K., Pedersen, S. F. Cell volume homeostatic mechanisms: effectors and signalling pathways. Acta Physiol (Oxf) 202(3), 465-85 (2011).
33. Cuddapah, V. A., Turner, K. L., Sontheimer, H. Calcium entry via TRPC1 channels activates chloride currents in human glioma cells. Cell Calcium 53(3), 187-94 (2013).
34. Catacuzzeno, L., Michelucci, A., Sforna, L. et al. Identification of key signaling molecules involved in the activation of the swellingactivated chloride current in human glioblastoma cells. J Membr Biol 247(1), 45-55 (2014).
35. Dardevet, L., Rani, D., Aziz, T. A. et al. Chlorotoxin: a helpful natural scorpion peptide to diagnose glioma and fight tumor invasion. Toxins (Basel) 7(4), 1079-101 (2015).
36. Turner, K. L., Sontheimer, H. Cl? and K+ channels and their role in primary brain tumour biology. Philos Trans R Soc Lond B Biol Sci 369(1638), 20130095 (2014).
37. Soroceanu, L., Gillespie, Y., Khazaeli, M. B. et al. Use of chlorotoxin for targeting of primary brain tumors. Cancer Res 58(21), 4871-9 (1998).
38. Fan, Z., Cao, L., He, Y. et al. Ctriporin, a new anti-methicillin-resistant Staphylococcus aureus peptide from the venom of the scorpion Chaerilus tricostatus. Antimicrob Agents Chemother 55(11), 5220-9 (2011).
39. Riva, P., Arista, A., Sturiale, C. et al. Treatment of intracranial human glioblastoma by direct intratumoral administration of 131I-labelled anti-tenascin monoclonal antibody BC-2. Int J Cancer 51(1), 7-13 (1992).
40. Paganelli, G., Bartolomei, M., Ferrari, M. et al. Pre-targeted locoregional radioimmunotherapy with 90Y-biotin in glioma patients: phase I study and preliminary therapeutic results. Cancer Biother Radiopharm 16(3), 227-35 (2001).
41. Deshane, J., Garner, C. C., Sontheimer, H. Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2. J Biol Chem 278(6), 4135-44 (2003).
42. Savaskan, N. E., Fan, Z., Broggini, T. et al. Neurodegeneration in the Brain Tumor Microenvironment: Glutamate in the Limelight. Current Neuropharmacology 13(2), 8 (2015).
43. Dubois, L. G., Campanati, L., Righy, C. et al. Gliomas and the vascular fragility of the blood brain barrier. Front Cell Neurosci 8, 418 (2014).